| 摘要 |
FIELD: chemistry.SUBSTANCE: invention relates to peptides (glucagon and/or GLP-1 and analogues thereof), covalently bound with surface-active glycosides, intended for treating or preventing disorders associated with insulin resistance.EFFECT: modification of peptides promotes longer action and/or increased bioavailability of peptides.17 cl, 1 tbl, 3 dwg, 8 ex |
